# US 2004/0082784 A1 · Pyridino and pyrimidino pyrazinones

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082784 A1
- Document ID: US20040082784A1
- Status: Published application
- Kind: A1
- Application number: 10/670,519
- Filed: 2003-09-26
- Published: 2004-04-29
- Earliest claimed: 2002-09-30
- Assignees: Bristol-Myers Squibb Company
- Inventors: Thais Motria Sielecki-Dzurdz; Argyrios George Arvanitis; Carolyn Diane Dzierba
- Web page: https://patentgrep.com/patent/US20040082784A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/24: Antidepressants
- C07D 475/00: Heterocyclic compounds containing pteridine ring systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides compounds of Formula I: 1 wherein the variables A, B, Ar, R1, R2, and R3 are as defined herein. The compounds of Formula (I) can function as corticotropin releasing factor (CRF) receptor antagonists and can be useful, for example, in the treatment of disorders characterized by abnormal levels of CRF such as anxiety and depression.

## Claims

### Claim 1

A compound of Formula (I):
90
or a pharmaceutically acceptable salt form thereof, or prodrug thereof, or radiolabeled form thereof, wherein:
A and B are independently CR4 or N, with the proviso that at least one of A and B is N;
Ar is aryl or heteroaryl, wherein said aryl or heteroaryl is optionally substituted by one or more substituents independently selected from C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, halogen, CN, NO2, OR5, and SR5;
R1 is H, CN, C1-C4 haloalkyl, NR1cR1d, NR1cCOR1b, COR1b, CONR1cR1d, OR1c, SR1c, C1-C4 alkyl substituted with 0 to 3 R1a, C2-C4 alkenyl substituted with 0 to 3 R1a, C2-C4 alkynyl substituted with 0 to 3 R1a, C3-C6 cycloalkyl substituted with 0 to 3 R1a, or C4-C8 cycloalkylalkyl substituted with 0 to 3 R1a, with the proviso that R1 is not CH2X, wherein X is halogen;
each R1a is, independently at each occurrence, halogen, CN, N3, NO2, C1-C2 haloalkyl, NR1cR1d, NR1cCOR1b, COR1b, OR1c, SR1c, S(O)R8, or S(O)2R8;
each R1b is, independently at each occurrence, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C2-C4 alkenyl, or C2-C4 alkynyl;
each R1c is, independently at each occurrence, selected from H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C2-C4 alkenyl, or C2-C4 alkynyl;
each R1d is, independently at each occurrence, selected from H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C2-C4 alkenyl, or C2-C4 alkynyl;
R2 is H, C1-C3 haloalkyl, CN, OH, COR2b, SH, SR2b, SO2NHR2c, SO2NR2cR2d, CONHR2c, CONR2cR2d, OCOR2b, OR2b, NR2cR2d, CO2R2b, C1-C4 alkyl substituted with 0 to 3 R2a, C2-C4 alkenyl substituted with 0 to 3 R2a, C2-C4 alkynyl substituted with 0 to 3 R2a, or C3-C6 cycloalkyl substituted with 0 to 3 R2a; with the proviso that R2 is not CH2X, wherein X is halogen;
each R2a is, independently at each occurrence, halogen, CN, N3, NO2, CF3, OR2c, NR2c, NR2cR2d, NR2cCO2R2b, SR2c, SOR8, SO2R8, CO2R2b, CONR2cR2d, COR2b, OCOR2b, NR2cCONR2cR2d, NR2cCO2R2b, OCONR2cR2d, piperidinyl, pyrrolidinyl, piperazinyl, N-methylpiperazinyl, morpholinyl, or thiomorpholinyl;
each R2b is, independently at each occurrence, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, aryl, heteroaryl, aryl-C1-C4 alkyl, or heteroaryl-C1-C4 alkyl;
each R2c is, independently at each occurrence, H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl aryl, heteroaryl, aryl-C1-C4 alkyl, or heteroaryl-C1-C4 alkyl;
each R2d is, independently at each occurrence, H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl aryl, heteroaryl, aryl-C1-C4 alkyl, or heteroaryl-C1-C4 alkyl;
R3 is OR3c, NR3cR3d, NHR3c, SR3c, SOR8, SO2R8, SO2NHR3c, SO2NR3cR3d, COR3c, CONHR3c, CONR3cR3d, aryl substituted with 0 to 3 R3a, heteroaryl substituted with 0 to 3 R3a, heterocyclyl substituted with 0 to 3 R3f, C1-C10 alkyl substituted with 0 to 3 R3a, C3-C10 alkenyl substituted with 0 to 3 R3a, C3-C10 alkynyl substituted with 0 to 3 R3a, C3-C8 cycloalkyl substituted with 0 to 3 R3a, C4-C12 cycloalkylalkyl substituted with 0 to 3 R3a, C2-C10 alkoxyalkyl substituted with 0 to 3 R3a, C2-C10 thioalkoxyalkyl substituted with 0 to 3 R3a, C5-C10 cycloalkenyl substituted with 0 to 3 R3a, or C6-C10 cycloalkenylalkyl substituted with 0 to 3 R3a, wherein one carbon in any cycloalkyl moiety is optionally replaced with O, S or NR5;
each R3a is, independently at each occurrence, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C6 cycloalkyl, halogen, C1-C4 haloalkyl, CN, OR3c, SR3c, S(O)R8, S(O)2R8, COR3b, NHR3cSO2R3b, OC(O)NR3cR3d, N3, OC(O)OR3b, CO2R3c, OC(O)R3b, NR3cCOR3b, N(COR3b)2, NR3cCONR3cR3d, NR3cCO2R3b, NR3cR3d, CONR3cR3d, aryl, heteroaryl, or heterocyclyl;
each R3b is, independently at each occurrence, C1-C10 alkyl substituted with 0 to 3 R3e, C2-C10 alkenyl substituted with 0 to 3 R3e, C2-C10 alkynyl substituted with 0 to 3 R3e, C3-C8 cycloalkyl substituted with 0 to 3 R3e, C4-C12 cycloalkylalkyl substituted with 0 to 3 R3e, C2-C10 alkoxyalkyl substituted with 0 to 3 R3e, C5-C10 cycloalkenyl substituted with 0 to 3 R3e, or C6-C10 cycloalkenylalkyl substituted with 0 to 3 R3e, wherein one carbon in any cycloalkyl moiety is optionally replaced with O, S or NR5;
each R3c is, independently at each occurrence, H, C1-C10 alkyl substituted with 0 to 3 R3e, C2-C10 alkenyl substituted with 0 to 3 R3e, C2-C10 alkynyl substituted with 0 to 3 R3e, C3-C8 cycloalkyl substituted with 0 to 3 R3e, C4-C12 cycloalkylalkyl substituted with 0 to 3 R3e, C2-C10 alkoxyalkyl substituted with 0 to 3 R3e, C5-C10 cycloalkenyl substituted with 0 to 3 R3e, or C6-C10 cycloalkenylalkyl substituted with 0 to 3 R3e, wherein one carbon in any cycloalkyl moiety is optionally replaced with O, S or NR5;
each R3d is, independently at each occurrence, H, C1-C10 alkyl substituted with 0 to 3 R3e, C2-C10 alkenyl substituted with 0 to 3 R3e, C2-C10 alkynyl substituted with 0 to 3 R3e, C3-C8 cycloalkyl substituted with 0 to 3 R3e, C4-C12 cycloalkylalkyl substituted with 0 to 3 R3e, C2-C10 alkoxyalkyl substituted with 0 to 3 R3e, C5-C10 cycloalkenyl substituted with 0 to 3 R3e, or C6-C10 cycloalkenylalkyl substituted with 0 to 3 R3e, wherein one carbon in any cycloalkyl moiety is optionally replaced with O, S or NR5;
each R3e is, independently at each occurrence, C1-C6 alkyl, C2-C6 alkenyl, C2-C10 alkynyl, C3-C6 cycloalkyl, halogen, C1-C4 haloalkyl, CN, OR7a, SR7a, S(O)nR8, COR6, CO2R7a, OC(O)R6, NR7aCOR6, N(COR6)2, NR7aCONR7aR7b, NR7aCO2R6, NR7aR7b, NHR7aSO2R6, OC(O)NR7aR7b, N3, OC(O)OR6, CONR7aR7b, aryl, heteroaryl, or heterocyclyl;
each R3f is, independently at each occurrence, oxo, sulfido, or R3a;
R4 is H, halogen, CN, C1-C3 haloalkyl, COR4b, OR4c, SR4c, SO2NHR4c, SO2NR4cR4d, CONHR4c, CONR4cR4d, OCOR4b, NR4cCONHR4c, NR4cCONR4cR4d, NR4cCO2R4b, OCONR4cR4d, NR4cR4d, CO2R4b, C1-C4 alkyl substituted with 0 to 1 R4a, C2-C4 alkenyl substituted with 0 to 1 R4a, C2-C4 alkynyl substituted with 0 to 1 R4a, C3-C6 cycloalkyl substituted with 0 to 1 R4a, piperidinyl, pyrrolidinyl, piperazinyl, N-methylpiperazinyl, morpholinyl, or thiomorpholinyl;
each R4a is, independently at each occurrence, halogen, CN, CF3, OR4c, NHR4c, NR4cR4d, NR4cCO2R4b, SR4c, SOR8, SO2R8, CO2R4b, CONHR4c, CONR4cR4d, COR4b, OCOR4b, NR4cCONR4cR4d, NR4cCO2R4b, OCONR4cR4d, piperidinyl, pyrrolidinyl, piperazinyl, N-methylpiperazinyl, morpholinyl, or thiomorpholinyl;
each R4b is, independently at each occurrence, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, aryl, heteroaryl, aryl-C1-C4 alkyl, or heteroaryl-C1-C4 alkyl;
each R4c is, independently at each occurrence, H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, aryl, heteroaryl, aryl-C1-C4 alkyl, or heteroaryl-C1-C4 alkyl;
each R4d is, independently at each occurrence, H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, aryl, heteroaryl, aryl-C1-C4 alkyl, or heteroaryl-C1-C4 alkyl;
R5 is H, C1-C4 alkyl, C1-C4 haloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, or C2-C6 alkoxyalkyl;
R6 is, independently at each occurrence, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, C2-C8 alkoxyalkyl, C5-Cl2 bis(alkoxy)alkyl, aryl, aryl-C1-C4 alkyl, heteroaryl, or heteroaryl-C1-C4 alkyl;
each R7a is, independently at each occurrence, H, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, C2-C8 alkoxyalkyl, C5-C12 bis(alkoxy)alkyl, aryl, aryl-C1-C4 alkyl, heteroaryl, or heteroaryl-C1-C4 alkyl;
each R7b is, independently at each occurrence, H, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, C2-C8 alkoxyalkyl, C5-C12 bis(alkoxy)alkyl, aryl, aryl-C1-C4 alkyl, heteroaryl, or heteroaryl-C1-C4 alkyl; and
R8 is C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, aryl, heteroaryl, aryl-C1-C4 alkyl, or heteroaryl-C1-C4 alkyl, or NR7aR7b.

### Claim 2 (depends on 1)

The compound of claim 1, of Formula (Ia):
91

### Claim 3 (depends on 2)

The compound of claim 2 wherein A is N.

### Claim 4 (depends on 2)

The compound of claim 2 wherein A is CR4.

### Claim 5 (depends on 2)

The compound of claim 2 wherein Ar is aryl.

### Claim 6 (depends on 5)

The compound of claim 5 wherein said aryl is phenyl substituted with 0 to 5 substituents or naphthyl substituted with 0 to 7 substituents, wherein each of said substituents is independently selected from, at each occurrence, C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, halogen, CN, NO2, OR5, and SR5.

### Claim 7 (depends on 2)

The compound of claim 2 wherein Ar is heteroaryl.

### Claim 8 (depends on 7)

The compound of claim 7 wherein said heteroaryl comprises a six-membered ring.

### Claim 9 (depends on 8)

The compound of claim 8 wherein said heteroaryl is pyridyl or pyrimidinyl, wherein said heteroaryl is substituted with 0 to 4 substituents, wherein each of said substituents is independently selected from, at each occurrence, C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, halogen, CN, NO2, OR5, and SR5.

### Claim 10 (depends on 7)

The compound of claim 7 wherein said heteroaryl comprises a five-membered ring.

### Claim 11 (depends on 10)

The compound of claim 10 wherein said heteroaryl is oxazolyl, isoxazolyl, or thienyl, wherein said heteroaryl is substituted with 0 to 4 substituents, wherein each of said substituents is independently selected from, at each occurrence, C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, halogen, CN, NO2, OR5, and SR5.

### Claim 12 (depends on 2)

The compound of claim 2 wherein R1 is H, CN, OH, C1-C4 alkyl, or C1-C2 haloalkyl.

### Claim 13 (depends on 2)

The compound of claim 2 wherein R1 is C1-C4 alkyl.

### Claim 14 (depends on 2)

The compound of claim 2 wherein R2 is H, CN, OH, SH, OR2b, SR2b, C1-C3 haloalkyl, or C1-C4 alkyl substituted with 0 to 3 R2a.

### Claim 15 (depends on 2)

The compound of claim 2 wherein R2 is H.

### Claim 16 (depends on 2)

The compound of claim 2 wherein R3 is S(O)R8, S(O)2R8, COR3c, CONHR3c, CONR3cR3d, C1-C8 alkyl substituted with 0 to 3 R3a, C3-C8 alkenyl substituted with 0 to 3 R3a, C3-C8 alkynyl substituted with 0 to 3 R3a, C3-C6 cycloalkyl substituted with 0 to 3 R3a, or C4-C10 cycloalkylalkyl substituted with 0 to 3 R3a, wherein one carbon in any cycloalkyl moiety is optionally replaced with O, S or NR5.

### Claim 17 (depends on 2)

The compound of claim 2 wherein R3 is C1-C6 alkyl substituted with 0 to 2 R3a.

### Claim 18 (depends on 2)

The compound of claim 2 wherein each R3a is, independently at each occurrence, methyl, ethyl, propyl, cyclopropyl, cyclobutyl, F, Cl, Br, CF3, CN, C1-C10 alkyl, C2-C10 alkenyl, OR3c, SR3c, COR3b, NHR3cSO2R3b, OC(O)NR3cR3d, N3, OC(O)OR3b, CO2R3c, OC(O)R3b, NR3cCOR3b, N(COR3b)2, NR3cCONR3cR3d, NR3cCO2R3b, NR3cR3d, or CONR3cR3d.

### Claim 19 (depends on 2)

The compound of claim 2 wherein R4 is H, CN, OH, C1-C4 alkyl, C1-C3 haloalkyl, SR4c, or OR4c.

### Claim 20 (depends on 2)

The compound of claim 2 wherein R4 is H.

### Claim 21 (depends on 2)

A compound of claim 2 wherein:
R1 is H, CN, OH, SH, C1-C4 haloalkyl, methoxy, ethoxy, cyclopropyl, cyclobutyl, cyclopropylmethyl, cyclopropylethyl, cyclobutylmethyl, cyclobutylethyl, C1-C4 alkyl substituted with 0 to 3 R1a, C2-C4 alkenyl substituted with 0 to 3 R1a, or C2-C4 alkynyl substituted with 0 to 3 R1a;
R1a is F, Cl, Br, CN, NO2, OH, OCH3, CF3, CHF2, or OCF3;
R2 is H, CN, OH, NR2cR2d, C1-C3 alkyl substituted with 0 to 3 R2a, C1-C3 alkoxy, C1-C2 haloalkyl, or C1-C2 haloalkoxy;
R3 is SOR8, SO2R8, SO2NR3cR3d, COR3c, CONHR3c, CONR3cR3d, aryl substituted with 0 to 3 R3a, heteroaryl substituted with 0 to 3 R3a, heterocyclyl substituted with 0 to 3 R3f, C1-C10 alkyl substituted with 0 to 3 R3a, C3-C10 alkenyl substituted with 0 to 3 R3a, C3-C10 alkynyl substituted with 0 to 3 R3a, C3-C8 cycloalkyl substituted with 0 to 3 R3a, C4-C12 cycloalkylalkyl substituted with 0 to 3 R3a, C2-C10 alkoxyalkyl substituted with 0 to 3 R3a, C2-C10 thioalkoxyalkyl substituted with 0 to 3 R3a, C5-C10 cycloalkenyl substituted with 0 to 3 R3a, or C6-C10 cycloalkenylalkyl substituted with 0 to 3 R3a, wherein one carbon in any cycloalkyl moiety is optionally replaced with O, S or NR5;
R4 is H, halogen, CN, C1-C3 haloalkyl, OR4c, SR4c, NR4cR4d, CO2R4b, C1-C4 alkyl substituted with 0 to 1 R4a, or C3-C6 cycloalkyl substituted with 0 to 1 R4a;
each R4a is, independently at each occurrence, halogen, CN, CF3, OR4c, NHR4c, NR4cR4d, NR4cCO2R4b, SR4c, SOR8, SO2R8, CO2R4b, CONHR4c, CONR4cR4d, COR4b, OCOR4b, NR4cCONR4cR4d, NR4cCO2R4b, OCONR4cR4d;
R5 is H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, or C2-C6 alkoxyalkyl;
each R7a is, independently at each occurrence, H, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, or C2-C8 alkoxyalkyl; and
each R7b is, independently at each occurrence, H, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, or C2-C8 alkoxyalkyl.

### Claim 22 (depends on 21)

The compound of claim 21 wherein A is N.

### Claim 23 (depends on 21)

The compound of claim 21 wherein A is CR4.

### Claim 24 (depends on 21)

The compound of claim 21 wherein R1 is H, CN, OH, C1-C4 alkyl, or C1-C2 haloalkyl.

### Claim 25 (depends on 21)

The compound of claim 21 wherein R2 is H, CN, OH, methyl, ethyl, methoxy, OCF3, CF3, CHF2, CH2CF3, or CF2CH3.

### Claim 26 (depends on 21)

The compound of claim 21 wherein R2 is H.

### Claim 27 (depends on 21)

The compound of claim 21 wherein R3 is C1-C6 alkyl substituted with 0 to 2 R3a.

### Claim 28 (depends on 21)

The compound of claim 21 wherein R4 is H, CN, OH, C1-C4 alkyl, C1-C3 haloalkyl, SR4c, or OR4c.

### Claim 29 (depends on 21)

The compound of claim 21 wherein R4 is H.

### Claim 30 (depends on 21)

The compound of claim 21 wherein Ar is aryl.

### Claim 31

The compound of 30 wherein said aryl is phenyl substituted with 0 to 5 substituents or naphthyl substituted with 0 to 7 substituents, wherein each of said substituents is independently selected from, at each occurrence, C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, halogen, CN, NO2, OR5, and SR5.

### Claim 32 (depends on 21)

The compound of claim 21 wherein Ar is heteroaryl.

### Claim 33 (depends on 32)

The compound of claim 32 wherein said heteroaryl comprises a six-membered ring.

### Claim 34 (depends on 33)

The compound of claim 33 wherein said heteroaryl is pyridyl or pyrimidinyl, wherein said heteroaryl is substituted with 0 to 4 substituents, wherein each of said substituents is independently selected from, at each occurrence, C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, halogen, CN, NO2, OR5, and SR5.

### Claim 35 (depends on 32)

The compound of claim 32 wherein said heteroaryl comprises a five-membered ring.

### Claim 36 (depends on 35)

The compound of claim 35 wherein said heteroaryl is oxazolyl, isoxazolyl, or thienyl, wherein said heteroaryl is substituted with 0 to 4 substituents, wherein each of said substituents is independently selected from, at each occurrence, C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, halogen, CN, NO2, OR5, and SR5.

### Claim 37 (depends on 21)

A compound of claim 21 wherein:
Ar is phenyl, pyridyl, pyrimidinyl, oxazolyl, isoxazolyl, or thienyl, wherein said phenyl is substituted with 0 to 5 R9a and said pyridyl, pyrimidinyl, oxazolyl, isoxazolyl, or thienyl is substituted with 0 to 4 R9b;
R1 is H, CN, methyl, ethyl, methoxy, OH, or C1-C2 haloalkyl;
R2 is H, CN, OH, CH3, OCH3, CF3, CHF2, or OCF3;
R3 is S(O)R8, S(O)2R8, COR3c, CONHR3c, CONR3cR3d, C1-C8 alkyl substituted with 0 to 3 R3a, C3-C8 alkenyl substituted with 0 to 3 R3a, C3-C8 alkynyl substituted to 3 R3a, C3-C6 cycloalkyl substituted with 0 to 3 R3a, or C4-C10 cycloalkylalkyl substituted with 0 to 3 R3a, wherein one carbon in any cycloalkyl moiety is optionally replaced with O, S or NR5;
each R3a is, independently at each occurrence, methyl, ethyl, methoxy, ethoxy, thiomethoxy, thioethoxy, cyclopropyl, cyclobutyl, F, Cl, CF3 CHF2, CH3, or OCF3;
R4 is H, CHF2, CF3, methyl, ethyl, Cl, F, OH, SH, methoxy, thiomethoxy, CH2CF3, CF2CH3; and
each R9a and R9b is, independently at each occurrence, F, Cl, Br, CN, methyl, ethyl, propyl, methoxy, ethoxy, propoxy, isopropoxy, C1-C2 haloalkyl, or C1-C2 haloalkoxy.

### Claim 38 (depends on 37)

The compound of claim 37 wherein A is N.

### Claim 39 (depends on 37)

The compound of claim 37 wherein A is CR4.

### Claim 40 (depends on 37)

The compound of claim 37 wherein R2 is H.

### Claim 41 (depends on 37)

The compound of claim 37 wherein R3 is butyl, pentyl, hexyl, heptyl, methoxyethyl, methoxypropyl, methoxybutyl, methoxypentyl, methoxyhexyl, thiomethoxyethyl, thiomethoxypropyl, thiomethoxybutyl, thiomethoxypentyl, thiomethoxyhexyl, 1-cyclopropylpropyl, 1-cyclopropylbutyl, 1-cyclopropylpentyl, 1-cyclobutylpropyl, 1-cyclobutylbutyl, 1-cyclobutylpentyl, 1-cyclopropyl-1-(CF3)-methyl, 1-cyclopropyl-1-(CF3)-ethyl, 1-cyclopropyl-1-(CF3)-propyl, 1-cyclobutyl-1-(CF3)-methyl, 1-cyclobutyl-2-(CF3)-ethyl, 1-cyclobutyl-3-(CF3)-propyl, or (cyclopropyl)2CH.

### Claim 42 (depends on 37)

The compound of claim 37 wherein R4 is H.

### Claim 43 (depends on 37)

The compound of claim 37 wherein Ar is phenyl substituted with 0 to 5 R9a.

### Claim 44 (depends on 37)

The compound of claim 37 wherein Ar is pyridyl substituted with 0 to 4 R9b or pyrimidinyl substituted with 0 to 4 R9b.

### Claim 45 (depends on 37)

A compound of claim 37 wherein:
Ar is phenyl substituted with 0 to 3 substituents each independently selected from F, Cl, Br, CN, methyl, ethyl, propyl, methoxy, ethoxy, propoxy, isopropoxy, CF3, CHF2, and OCF3; or
Ar is pyridyl or pyrimidinyl substituted with 0 to 2 substituents each independently selected from F, Cl, Br, CN, methyl, ethyl, propyl, methoxy, ethoxy, propoxy, isopropoxy, CF3, CHF2, and OCF3;
R1 is H, CN, OH, methyl, ethyl, methoxy, or C1-C2 haloalkyl;
R2 is H;
R3 is C1-C6 alkyl substituted with 0 to 2 R3a; and
R4 is H.

### Claim 46 (depends on 45)

The compound of claim 45 wherein Ar is phenyl substituted with 0 to 3 substituents each independently selected from F, Cl, Br, CN, methyl, ethyl, propyl, methoxy, ethoxy, propoxy, isopropoxy, CF3, CHF2, and OCF3.

### Claim 47 (depends on 45)

The compound of claim 45 wherein Ar is pyridyl or pyrimidinyl substituted with 0 to 2 substituents each independently selected from F, Cl, Br, CN, methyl, ethyl, propyl, methoxy, ethoxy, propoxy, isopropoxy, CF3, CHF2, and OCF3.

### Claim 48 (depends on 47)

The compound of claim 47 wherein said pyridyl is pyrid-3-yl.

### Claim 49 (depends on 45)

The compound of claim 45 wherein A is N.

### Claim 50 (depends on 45)

The compound of claim 45 wherein A is CR4.

### Claim 51 (depends on 45)

The compound of claim 45 wherein R3 is butyl, pentyl, hexyl, heptyl, methoxyethyl, methoxypropyl, methoxybutyl, methoxypentyl, methoxyhexyl, thiomethoxyethyl, thiomethoxypropyl, thiomethoxybutyl, thiomethoxypentyl, thiomethoxyhexyl, 1-cyclopropylpropyl, 1-cyclopropylbutyl, 1-cyclopropylpentyl, 1-cyclobutylpropyl, 1-cyclobutylbutyl, 1-cyclobutylpentyl, 1-cyclopropyl-1-(CF3)-methyl, 1-cyclopropyl-1-(CF3)-ethyl, 1-cyclopropyl-1-(CF3)-propyl, 1-cyclobutyl-1-(CF3)-methyl, 1-cyclobutyl-2-(CF3)-ethyl, 1-cyclobutyl-3-(CF3)-propyl, or (cyclopropyl)2CH.

### Claim 52 (depends on 2)

A compound of claim 2 selected from:
(R)-8-(2,4-dichloro-phenyl)-4-isobutyl-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2,4-dichloro-phenyl)-4-isobutyl-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2,4-dichloro-phenyl)-2-methyl-4-(1-methyl-butyl)-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2,4-dichloro-phenyl)-2-methyl-4-(1-methyl-butyl)-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-4-(1-cyclopropyl-propyl)-8-(2,4-dichloro-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-cyclopropyl-propyl)-8-(2,4-dichloro-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2,4-dichloro-phenyl)-4-(1,2-dimethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2,4-dichloro-phenyl)-4-(1,2-dimethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-cyclopropyl-butyl)-8-(2,4-dichloro-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-4-(1-cyclopropyl-butyl)-8-(2,4-dichloro-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2,4-dichloro-phenyl)-4-(2-methoxy-1-methyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2,4-dichloro-phenyl)-4-(2-methoxy-1-methyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2,4-dichloro-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2,4-dichloro-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R,S)-8-(2-chloro-4-methoxy-phenyl)-2-methyl-4-(1-propyl-butyl)-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-methoxy-phenyl)-4-(1-cyclopropyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-methoxy-phenyl)-4-(1-cyclopropyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-methoxy-phenyl)-4-(1-cyclobutyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-methoxy-phenyl)-4-(1-cyclobutyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-methoxy-phenyl)-4-(2-methoxy-1-methyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-methoxy-phenyl)-4-(2-methoxy-1-methyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-methoxy-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-cylcopropropyl-propyl)-8-(4-methoxy-2-methyl-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-cyclopropyl-butyl)-8-(4-methoxy-2-methyl-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-4-(1-cyclopropyl-butyl)-8-(4-methoxy-2-methyl-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(2-methoxy-1-methyl-ethyl)-8-(4-methoxy-2-methyl-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-ethyl-pentyl)-8-(6-methoxy-2-methyl-pyridin-3-yl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-4-(1-ethyl-pentyl)-8-(6-methoxy-2-methyl-pyridin-3-yl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-cyclopropyl-propyl)-8-(6-methoxy-2-methyl-pyridin-3-yl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-cyclopropyl-butyl)-8-(6-methoxy-2-methyl-pyridin-3-yl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-4-(1-cyclopropyl-butyl)-8-(6-methoxy-2-methyl-pyridin-3-yl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(2-methoxy-1-methyl-ethyl)-8-(6-methoxy-2-methyl-pyridyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-sec-butyl-8-(2-chloro-4-difluoromethoxy-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-4-(1-cyclopropyl-butyl)-8-(6-methoxy-2-methyl-pyridin-3-yl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-difluoromethoxy-phenyl)-4-(1-cyclopropyl-propyl)2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-difluoromethoxy-phenyl)-4-(1-cyclopropyl-propyl)2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-difluoromethoxy-phenyl)-4-(1-cyclopropyl-butyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-difluoromethoxy-phenyl)-4-(1-cyclopropyl-butyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-difluoromethoxy-phenyl)-4-(2-methoxy-1-methyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-difluoromethoxy-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-difluoromethoxy-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-chloro-4-trifluoromethyl-phenyl)-4-(1-cyclopropyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-trifluoromethyl-phenyl)-4-(2-methoxy-1-methyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-chloro-4-trifluoromethyl-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-3-chloro-4-(4-(1-methoxymethylpropyl)-2-methyl-3-oxo-3,4-dihydro-pyrido[2,3-b]pyrazin-8-yl]-benzonitrile;
(R)-8-sec-butyl-4-(2,4-dichloro-phenyl)-6-methyl-8H-pteridin-7-one; and
(S)-8-sec-butyl-4-(2,4-dichloro-phenyl)-6-methyl-8H-pteridin-7-one.

### Claim 53 (depends on 2)

A compound of claim 2 selected from:
(R,S)-8-(4-Methoxy-2-methyl-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-4-(1-Cyclopropyl-propyl)-8-(5-fluoro-4-methoxy-2-methyl-phenyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(5-Fluoro-4-methoxy-2-methyl-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(S)-8-(2-Chloro-5-fluoro-4-methoxy-phenyl)-4-(1-cyclopropyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(2-Chloro-5-fluoro-4-methoxy-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(5-Chloro-4-methoxy-2-methyl-phenyl)-4-(1-cyclopropyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(5-Chloro-4-methoxy-2-methyl-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(2-Chloro-4-methoxy-5-methyl-phenyl)-4-(1-cyclopropyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(2-Chloro-4-methoxy-5-methyl-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(2-Chloro-4-dimethylamino-5-fluoro-phenyl)-4-(1-cyclopropyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-Chloro-4-dimethylamino-5-fluoro-phenyl)-4-(1-cyclopropyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
(R)-8-(2-Chloro-4-dimethylamino-5-fluoro-phenyl)-4-(1-cyclobutyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(2-Chloro-4-dimethylamino-5-fluoro-phenyl)-4-(2-methoxy-1-methyl-ethyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
8-(2-Chloro-4-dimethylamino-5-fluoro-phenyl)-4-(1-methoxymethyl-propyl)-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;
4-(2-Chloro-4-methoxy-phenyl)-6-methyl-8-(1-propyl-butyl)-8H-pteridin-7-one;
(R)-4-(2-Chloro-4-methoxy-phenyl)-8-(1-cyclopropyl-ethyl)-6-methyl-8H-pteridin-7-one;
(S)-4-(2-Chloro-4-methoxy-phenyl)-8-(1-cyclobutyl-ethyl)-6-methyl-8H-pteridin-7-one;
(R)-4-(2-Chloro-4-methoxy-phenyl)-8-(2-methoxy-1-methyl-ethyl)-6-methyl-8H-pteridin-7-one;
(R)-4-(2-Chloro-4-methoxy-phenyl)-8-(1-methoxymethyl-propyl)-6-methyl-8H-pteridin-7-one;
(R)-8-(1-Cyclopropyl-propyl)-4-(4-methoxy-2-methyl-phenyl)-6-methyl-8H-pteridin-7-one;
(R)-8-(1-Cyclopropyl-propyl)-4-(6-methoxy-2-methyl-pyridin-3-yl)-6-methyl-8H-pteridin-7-one;
(R)-8-(2-Methoxy-1-methyl-ethyl)-4-(6-methoxy-2-methyl-pyridin-3-yl)-6-methyl-8H-pteridin-7-one;
(R)-8-(1-Methoxymethyl-propyl)-4-(6-methoxy-2-methyl-pyridin-3-yl)-6-methyl-8H-pteridin-7-one;
(R)-4-(4-Methoxy-2,5-dimethyl-phenyl)-8-(1-methoxymethyl-propyl)-6-methyl-8H-pteridin-7-one;
(R)-4-(2-Chloro-4-trifluoromethoxy-phenyl)-8-(1-cyclopropyl-propyl)-6-methyl-8H-pteridin-7-one;
4-(2-Chloro-4-trifluoromethoxy-phenyl)-8-(1-cyclopropyl-ethyl)-6-methyl-8H-pteridin-7-one; and
(R)-4-(2-Chloro-4-trifluoromethoxy-phenyl)-8-(2-methoxy-1-methyl-ethyl)-6-methyl-8H-pteridin-7-one.

### Claim 54 (depends on 1)

A compound of claim 1 selected from the group consisting of:
(R)-5-(2,4-Dichloro-phenyl)-1-isobutyl-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2,4-Dichloro-phenyl)-1-isobutyl-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-propyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-propyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2,4-Dichloro-phenyl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2,4-Dichloro-phenyl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2,4-Dichloro-phenyl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2,4-Dichloro-phenyl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-ethyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-ethyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-propyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-propyl)-5-(2,4-dichloro-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclopropyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclopropyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclopropyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclopropyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclopropyl-2-methoxy-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclopropyl-2-methoxy-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclobutyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclobutyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclobutyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2-Chloro-5-fluoro-4-methoxy-phenyl)-1-(1-cyclobutyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-propyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-propyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(2-Methoxy-1-methyl-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(2-Methoxy-1-methyl-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Methoxymethyl-propyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Methoxymethyl-propyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-ethyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-propyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-propyl)-5-(6-methoxy-2-methyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-ethyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-ethyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-propyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-propyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(6-Methoxy-2,5-dimethyl-pyridin-3-yl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(6-Methoxy-2,5-dimethyl-pyridin-3-yl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(6-Methoxy-2,5-dimethyl-pyridin-3-yl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(6-Methoxy-2,5-dimethyl-pyridin-3-yl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-ethyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-ethyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-propyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-propyl)-5-(6-methoxy-2,5-dimethyl-pyridin-3-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-ethyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-ethyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-propyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-propyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(4-Methoxy-2,5-dimethyl-phenyl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(4-Methoxy-2,5-dimethyl-phenyl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(4-Methoxy-2,5-dimethyl-phenyl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(4-Methoxy-2,5-dimethyl-phenyl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-ethyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-ethyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-propyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-propyl)-5-(4-methoxy-2,5-dimethyl-phenyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-ethyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-ethyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-propyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclopropyl-propyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2,4-Dimethoxy-pyrimidin-5-yl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2,4-Dimethoxy-pyrimidin-5-yl)-1-(2-methoxy-1-methyl-ethyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-5-(2,4-Dimethoxy-pyrimidin-5-yl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-5-(2,4-Dimethoxy-pyrimidin-5-yl)-1-(1-methoxymethyl-propyl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclopropyl-2-methoxy-ethyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(-Cyclopropyl-2-methoxy-ethyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-ethyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-ethyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(R)-1-(1-Cyclobutyl-propyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one;
(S)-1-(1-Cyclobutyl-propyl)-5-(2,4-dimethoxy-pyrimidin-5-yl)-3-methyl-1H-pyrido[3,4-b]pyrazin-2-one.

### Claim 55 (depends on 1)

A composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

### Claim 56 (depends on 2)

A composition comprising a compound of claim 2 and a pharmaceutically acceptable carrier.

### Claim 57 (depends on 1)

A method of reducing symptoms caused by elevated levels of corticotropin releasing factor in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 1.

### Claim 58 (depends on 2)

A method of reducing symptoms caused by elevated levels of corticotropin releasing factor in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 2.

### Claim 59 (depends on 1)

A method of treating stress-related symptoms in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 1.

### Claim 60 (depends on 2)

A method of treating stress-related symptoms in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 2.

### Claim 61 (depends on 1)

A method of treating a disorder characterized by abnormal levels of corticotropin releasing factor in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 1.

### Claim 62 (depends on 61)

The method of claim 61 wherein said disorder is characterized by elevated levels of corticotropin releasing factor.

### Claim 63 (depends on 2)

A method of treating a disorder characterized by abnormal levels of corticotropin releasing factor in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 2.

### Claim 64 (depends on 63)

The method of claim 63 wherein said disorder is characterized by elevated levels of corticotropin releasing factor.

### Claim 65 (depends on 1)

A method of treating anxiety or depression in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 1.

### Claim 66 (depends on 2)

A method of treating anxiety or depression in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 2.

### Claim 67 (depends on 1)

A method of treating irritable bowel syndrome in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 1.

### Claim 68 (depends on 2)

A method of treating irritable bowel syndrome in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 2.
